Clinical trial of acetylenic carbamate: 1,1-diphenyl-2-propynyl cyclohexanecarbamate (NSC-112682)
Gailani, S.; Blais, M.
Cancer ChemoTherapy Reports 54(3): 187-190
1970
ISSN/ISBN: 0069-0112 PMID: 4334087 Document Number: 21061
Document emailed within 1 workday
Related Documents
Bruno, O.; Ranise, A.; Bondavalli, F.; Schenone, P.; D'Amico, M.; Filippelli, A.; Filippelli, W.; Rossi, F. 1993: 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities Farmaco 48(7): 949-966Ranise, A.; Bruno, O.; Schenone, S.; Bondavalli, F.; Falcone, G.; Filippelli, W.; Sorrentino, S. 1997: Synthesis of 6-thiosubstituted 5-ethoxycarbonyl-1,3-diphenyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-ones, 6-substituted 5-hydroxy-1,3-diphenyl-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-ones and their esters with local anesthetic, antiarrhythmic, antiinflammatory and analgesic activities Farmaco 52(8-9): 547-555
Spinner, D.; Walter, J.; Vazquez-Gragg, M.; Bloise, T.; Stafford-Smith, M.; Faulkner, E.; Taekman, J. 2011: Php74 Clinical Trial Learning Curves Affect Outcomes Measurement, Patient Safety and Trial Success: Contributing Factors and a Potential Solution in Clinical Trial Simulation Value in Health 14(3): A24-A25
Vassena, E.; Chierichetti, S. 1974: Clinical evaluation of the antipyretic activity of 4-prenyl-1,2-diphenyl-3,5-pyrazolidindione in pediatrics Minerva Pediatrica 26(10): 537-543
Trindade, M.D. 1964: Use of a Suppository of 4,4-Diacetoxy-Diphenyl-Pyridyl-2-Methane in Hospital Clinical Practice Hospital (Rio de Janeiro) 66: 617-623
Regelson, W.; Hananian, J.; Bozzini, M.; Ambrus, C.M.; Bardos, T.J.; Ambrus, J.L. 1975: Laboratory and clinical evaluation of the radiation-potentiating activity of ethyl-N-bis (2,2-dimethylethylamidinophosphoro) carbamate (AB-132) Journal of Medicine 6(2): 121-135
Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P.; Lang, T. 2011: The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial Trials 12: 145
Galler, A.S.; Bauer, T.L. 2009: A randomised phase II trial of preoperative chemotherapy of cisplatindocetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) Yearbook of Oncology 2009: 194-195
Batzold, F.H.; Covey, D.F.; Robinson, C.H. 1977: Effects of novel acetylenic and allenic steroids on the rat prostate Cancer Treatment Reports 61(2): 255-257
Hu, D.; Xu, Z. 1997: Multicenter clinical trial of thrombolytic therapy in 1,406 patients with acute myocardial infarction. Collaborative Group of Clinical Trial for Urokinase Therapy Chinese Medical Journal 110(11): 839-842
Cruces, M.A.; Elorriaga, C.; Fernandez Alvarez, E.; Lopez Chico, M.T.; Nieto Lopez, O. 1988: Acetylenic and allenic derivatives of 2-(1-methylindolyl) methylamine as selective inhibitors of the monoamine oxidases a and B Il Farmaco; Edizione Scientifica 43(7-8): 567-573
Buick, A.R.; Sheung, C.T. 1993: Determination of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)-uracil and a metabolite, 5-propynyluracil, in plasma using ASTED (automated sequential trace enrichment of dialysates) combined, on-line, with high-performance liquid chromatography Journal of Chromatography 617(1): 65-70
Chien, D.S.; Sandri, R.B.; Tang-Liu, D.S. 1992: Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(2): 211-217
Valoti, M.; Costanzo, M.; Sgaragli, G.P.; Perez, V.; Fernandez-Alvarez, E.; Unzeta, M. 1994: Interactions of monoamine oxidase inhibitors, N-acetylenic analogues of tryptamine, with rat liver microsomal cytochrome P450 Journal of Pharmacy and Pharmacology 46(5): 360-365
Ndebele, P.M.; Wassenaar, D.; Munalula, E.; Masiye, F. 2012: Improving understanding of clinical trial procedures among low literacy populations: an intervention within a microbicide trial in Malawi Bmc Medical Ethics 13: 29
Evans, S.; Pocock, S. 2001: Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial Bmj 322(7286): 569-570
Katayose, Y.; Yamamoto, K.; Nakagawal, K.; Takemura, S.; Takahashi, M.; Nakamura, R.; Shimamura, H.; Rikiyama, T.; Egawa, S.; Yoshda, H.; Motoi, F.; Naitoh, T.; Unno, M. 2015: Feasibility Assessment of Modified FOLFOX-6 as adjuvant treatment after resection of liver metastases from colorectal cancer: analyses of a multicenter phase II clinical trial (Miyagi-HBPCOG Trial-001) Hepato-Gastroenterology 62(138): 303-308
Overduin, L.M. 1992: Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. the Phenytoin Trial Group on Canine Epilepsy Tijdschrift Voor Diergeneeskunde 117(Suppl 1): 27s-28s
Alves, J.Guilherme.B.; de Araújo, C.Adriane.Fonseca.Leal.; Pontes, I.E.A.; Guimarães, Aélica.C.; Ray, J.G. 2014: The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity Bmc Pregnancy and Childbirth 14: 222
Vichkanova, S.A.; Tolkachev, O.N.; Makarova, L.V.; Tsizin, I.S. 1974: Structure and antitubercular activity of some diphenyl esters Farmakologiia i Toksikologiia 37(6): 711-715